Cargando…
Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort
INTRODUCTION: Several clinical studies have reported the efficacy of favipiravir in reducing viral load and shortening the duration of symptoms. However, the viability of SARS-CoV-2 in the context of favipiravir therapy and the potential for resistance development is unclear. METHODS: We sequenced S...
Autores principales: | Suzuki, Masahiro, Imai, Takumi, Sakurai, Aki, Komoto, Satoshi, Ide, Tomihiko, Lim, Chang Kweng, Shintani, Ayumi, Doi, Yohei, Murata, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196299/ https://www.ncbi.nlm.nih.gov/pubmed/34176716 http://dx.doi.org/10.1016/j.jiac.2021.06.010 |
Ejemplares similares
-
Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers
por: Murata, Takayuki, et al.
Publicado: (2021) -
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19
por: Doi, Yohei, et al.
Publicado: (2020) -
Porcine Rotavirus Closely Related to Novel Group of Human Rotaviruses
por: Wakuda, Mitsutaka, et al.
Publicado: (2011) -
Lung Pathology of Mutually Exclusive Co-infection with SARS-CoV-2 and Streptococcus pneumoniae
por: Tsukamoto, Tetsuya, et al.
Publicado: (2021) -
Favipiravir for symptomatic COVID-19: A nationwide observational cohort study
por: Doi, Yohei, et al.
Publicado: (2023)